0
NPS Score
VS
Esperion Therapeutics Claimed Company
- EMPLOYEE
PARTICIPANTS - 20
- TOTAL
RATINGS
Neurocrine Biosciences
- EMPLOYEE
PARTICIPANTS - 11
- TOTAL
RATINGS
Esperion Therapeutics vs Neurocrine Biosciences
Compare Esperion Therapeutics versus Neurocrine Biosciences for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 20 employees and customers of Esperion Therapeutics and 11 employees and customers of Neurocrine Biosciences.
Esperion Therapeutics
Esperion Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Esperion Therapeutics. Their current market cap is $129.76M.
Neurocrine Biosciences
Neurocrine Biosciences's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Neurocrine Biosciences. Their current market cap is $9.11B.
3.3/5
Product Quality
5/5
2.7/5
Pricing
1.5/5
3.1/5
Customer Service
1.5/5
| 45% | Promoters |
|---|---|
| 10% | Passive |
| 45% | Detractors |
Net Promoter Score
Winner by 50
-50
NPS Score
| 0% | Promoters |
|---|---|
| 50% | Passive |
| 50% | Detractors |
See how Esperion Therapeutics compares to its competitors
See how Neurocrine Biosciences compares to its competitors
Working at Esperion Therapeutics vs Working at Neurocrine Biosciences
22 / 100
CEO Rating
61 / 100
CEO Rating
Winner by 39%
Esperion Therapeutics
Esperion Therapeutics doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Neurocrine Biosciences
Employees at Neurocrine Biosciences rate their CEO, Kevin Gorman, 61/100. This score is 39% higher than the scores of Esperion Therapeutics' CEO, Timothy Mayleben.